COVID-19 (PASC) 后急性后续症的症状和病理生理学:一个队列研究
Olivier Robineau1, Sophie Hüe2, Mathieu Surenaud2
1Sorbonne Université, Inserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Paris, France; EA2694, Centre Hospitalier de Tourcoing, Univ Lille, France.
EBioMedicine
|May 31, 2025
概括
在轻度病例中,COVID-19 (PASC) 后急性后续的机制尚不清楚. 生物标志物将一些PASC症状与病毒和血管激活联系起来,但这些关联随着时间的推移而变化.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 病理生理学 病理生理学
背景情况:
- 虽然已知COVID-19的长期后果,但轻度病例的PASC机制尚未得到充分研究.
- PASC与免疫/炎症问题之间的联系是不一致的.
- 探索持续症状的多种病理生理机制至关重要.
研究的目的:
- 在患有轻度COVID-19的个体中调查PASC的病理生理机制.
- 分析持续症状和血液生物标志物之间的关联.
- 比较PASC患者与康复个体的生物标志物概况.
主要方法:
- 预期的COPER队列研究非住院的个人与没有PASC.
- 在六个月间的两次家庭访问中采集生物样本和问卷.
- 对14个与持续症状相关的血液生物标志物的分析.
主要成果:
- PASC患者 (n=311) 更常见的是女性,BMI较高,患有喘息,呼吸不全,咳,睡眠障碍.
- 病毒 (IFNγ,IP-10),严重程度 (CD163) 和血管 (VCAM-1,ICAM-1) 激活的生物标志物与PASC症状相关 <1年.
- 生物标志物和PASC症状之间的关联并没有随着时间的推移而持续.
结论:
- 帕斯克病理生理学似乎多态和动态,根据症状和感染后的时间而异.
- 除了持续性炎症之外的机制可能解释PASC.
- 对各种病理生理路径的进一步研究是有必要的.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
544
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
544
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
54
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
54
01:29Pneumonia II: Pathophysiology
622
The pathophysiology of pneumonia involves the following steps:
622
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:26Stages of Infection
59.3K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
59.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K